Aromatase Inhibitor-Induced Hair Loss in Two Adolescents

    September 2020 in “ Pediatric Dermatology ”
    Marina Perper, Ingrid Herskovitz, Antonella Tosti
    Studysummary In this case report, two adolescents developed androgenetic alopecia after treatment with anastrozole for idiopathic short stature, suggesting this potential side effect should be considered in pediatric patients using aromatase inhibitors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Oral Minoxidil Treatment for Hair Loss: A Review of Efficacy and Safety Journal of The American Academy of Dermatology · 2020
    2. Pediatric Androgenetic Alopecia: A Review Journal of The American Academy of Dermatology · 2019
    3. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
    4. Management of Hair Loss Associated with Endocrine Therapy in Patients with Breast Cancer: An Overview SpringerPlus · 2016
    5. Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors Breast Cancer Research and Treatment · 2013
    6. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    7. Low-Level Laser Therapy for Treatment of Hair Loss Lasers in Surgery and Medicine · 2013
    8. Aromatase Inhibitors Induce Male Pattern Hair Loss in Women Annals of Oncology · 2013
    9. Androgenetic Alopecia in the Pediatric Population: A Retrospective Review of 57 Patients British Journal of Dermatology · 2010
    10. Androgenetic Alopecia in Children: Report of 20 Cases British Journal of Dermatology · 2005